Clinical Trial

The Impact of Surgeon-Interpreted Intraoperative Margin Assessment During Breast Conserving Surgery on Postoperative Treatment

Suspended
View on ClinicalTrials.gov →
Why the trial stopped
PI Request
Summary
To learn if Pegulicianine Fluorescence-Guided Surgery (pFGS), which is part of the Lumicell Direct Visualization System, and Digital Breast Tomosynthesis (DBT) can improve the identification of tumor margins during a partial mastectomy and decrease the need for a second surgery.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-08-21; most recent amendment 2026-04-10.
Status change: Active, Not Recruiting → Suspended 2026-03-17
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-10-21
Trial Details
NCT Number NCT07140965
Lead Sponsor M.D. Anderson Cancer Center
Conditions Breast Cancer
Enrollment 175 participants
Start Date 2025-10-09
Primary Completion 2027-09-30 (estimated)
Study Completion 2029-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-14